Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 16, 1995New England Journal of Medicine

Doxorubicin-Induced Cardiotoxicity

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

JSJ H SilberGBG Barber

Discussion

Loading...

Member takes

Overview

Provides synthesis for guiding cardioprotection during anthracycline therapy; leaves open gaps for targeted pathway-specific interventions.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Silber et al. (1995) studied this question.

synapsesocial.com/papers/6a7f077bcda104a52269a600https://doi.org/10.1056/nejm199511163332015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management2024 · 4 citations
  2. 2Doxorubicin-induced Cardiomyopathy: Mechanisms, Diagnosis and Therapeutic Drugs2022 · 2 citations
  3. 3Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity2016 · 38 citations
  4. 4Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management2022 · 3 citations
  5. 5Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation2022 · 95 citations